Onto Innovation (ONTO) Stock Jump: The $720M Rigaku X-Ray Stake, Explained

Summary

On Tuesday, August 11, 2026, Onto Innovation (NYSE: ONTO) rose about 5.9% to roughly $308.4 from a $291.35 prior close, an intraday move the site's Change Feed flagged to an undisclosed 8-K [3][4]. That filing, dated August 10, is the closing of Onto's ~$720 million acquisition of a 27% strategic minority stake in Rigaku Holdings — the Japanese X-ray-instruments maker — deepening a process-control partnership the two struck in April 2026 [1][5]. It landed just days after Onto's August 6 record second quarter: revenue of $343.1 million, up 35% year over year, adjusted EPS of $1.93 against a ~$1.69 consensus, and a raised full-year advanced-packaging growth outlook of ~80% [2][6]. With semiconductor process-control peers also firm on the day, the honest read is a blend: a deal-completion catalyst amplifying still-fresh post-earnings momentum in one of the AI supply chain's best-positioned names.

What changed

The specific news on the tape was the Rigaku stake closing. Onto completed the purchase of 61,123,436 shares — about 27% of Rigaku's outstanding stock — from an affiliate of Carlyle for roughly $720 million, a deal first announced in April 2026 [1][5]. Strategically, it locks in Onto's push into X-ray process control: as chips move to 3D stacking, hybrid bonding and high-bandwidth memory (HBM), X-ray metrology becomes a way to see defects and overlay errors that optical tools miss. Onto gets board representation (it can nominate one director) but will account for the stake at fair value without consolidating Rigaku's results, so this is a strategic and financial position rather than an acquisition that folds into revenue [1].

The reason the market cared, though, is the quarter underneath it. On August 6 Onto reported the strongest print in its history and told a clean AI story [2][6]:

• Revenue $343.1M, up 18% sequentially and 35% year over year, ahead of the ~$325M consensus [2].
• Adjusted EPS $1.93 vs ~$1.69 expected; gross margin 57% [2].
• Advanced-packaging full-year growth outlook raised to ~80%, from a prior ~50%; advanced-nodes revenue guided to grow more than 35% for 2026 [2].
• Q3 revenue guidance of $380–400M — a step up from Q2's record — with backlog above $1.1 billion, extending into 2027 [2].
• Dragonfly inspection demand cited as "unprecedented," including a single OSAT order of over $200 million for HBM and 2.5D packaging, most shipping in 2027 [2].

Why a pop on a pre-announced deal?

A ~6% jump on the closing of a stake announced back in April is bigger than the news alone justifies, which is the tell that more than one thing is happening. Three forces line up: the 8-K confirms the X-ray strategy is now executed rather than pending; the market is still digesting the August 6 blowout and the wave of target hikes that followed; and the process-control group was bid the same day. This was not a lone-stock move against a flat sector — it was a leader outrunning a rising tide.

Why it matters

Process control is where the AI-packaging boom quietly concentrates. As logic and memory move from shrinking transistors to stacking and bonding them, the hard problem shifts to seeing and measuring — inspection, metrology and the software that ties them together — which is Onto's franchise. The Rigaku stake is a bet that X-ray becomes a required tool in that stack, and owning a piece of the leading X-ray maker is a cheaper, faster way in than building it. It rhymes with the broader semiconductor-equipment re-rating we've tracked in the WFE names and with the HBM/memory capex cycle that ultimately drives Onto's tools.

How the peers and sector traded the same day

Unlike a pure single-stock event, Onto moved with a firm process-control group — but led it. With the S&P 500 roughly flat (−0.06%), the metrology/inspection complex was green, and ONTO roughly doubled the group's move on its own catalyst [10]:

The group being green matters for attribution: some of Onto's move is the same AI-metrology bid lifting KLA and Camtek, not purely the Rigaku close. But leading the pack by ~2x on the day it executed a strategic deal is the market rewarding the stock specifically.

What to watch

The quarter set a high bar; these are the tells for whether the re-rating holds:

• Q3 delivery against the $380–400M guide — Onto is guiding sequential acceleration; a beat-and-raise keeps the momentum, an in-line print into a ~30x multiple may not [2].
• Advanced-packaging conversion — the ~80% growth outlook and the $1.1B+ backlog only help if HBM/2.5D orders (including the $200M+ OSAT award) ship on schedule into 2027 [2].
• What Rigaku actually adds — watch for a roadmap tying the X-ray stake to specific tool wins; until then it is a strategic option, fair-value-accounted, not an earnings driver [1].
• Memory-capex cyclicality — memory is ~60% of advanced nodes; any HBM/DRAM capex digestion would hit the most cyclical part of the story fast [2].
• Whether the multiple can be fed — at ~30x forward and +195% in a year, the stock needs estimate revisions to keep rising. The next print lands on our earnings calendar, and moves are tracked on the ONTO stock page [8].

Illustrative valuation scenarios

The scenarios below are a descriptive, probability-weighted price-anchor exercise — not a forecast or a recommendation. The high end is anchored to named, dated analyst targets (Jefferies $400); the probabilities are the author's own illustrative estimates and sum to 100%.

Blending those (0.35 × $400 + 0.40 × $355 + 0.25 × $250) gives a probability-weighted anchor near $345, versus the ~$308 intraday price and the ~$382 average target [3][8]. The anchor sits above the price but below consensus — the stock has already captured much of the good news, so from here the upside leans on continued estimate revisions rather than a simple gap-to-target close. This is descriptive analysis of a corporate event, not investment advice.

Why is Onto Innovation (ONTO) stock up today?

Onto Innovation rose about 5.9% to ~$308 on August 11, 2026 after an August 10 8-K disclosed the closing of its ~$720 million acquisition of a 27% strategic stake in Rigaku Holdings, an X-ray process-control maker [1][3]. The move extended a rally that began with Onto's August 6 record second quarter — revenue $343.1M (+35% YoY), adjusted EPS $1.93, and a raised ~80% advanced-packaging growth outlook — and coincided with a firm day for process-control peers [2][11].

ONTO data snapshot — August 11, 2026 (timestamped)

Each figure is valid only at its stated time; three independent feeds (StockAnalysis, this site's own, and FinViz) agree to within a few cents on both price and the ~5.9% move.

The catalyst at a glance